Last Price
0.889
Today's Change
+0.513 (136.80%)
Day's Change
0.426 - 1.27
Trading Volume
186,875,117
Market Cap
17 Million
Shares Outstanding
20 Million
Avg Volume
883,828
Avg Price (50 Days)
0.58
Avg Price (200 Days)
1.99
PE Ratio
-1.13
EPS
-0.76
Earnings Announcement
12-Nov-2024
Previous Close
0.38
Open
0.50
Day's Range
0.4257 - 1.27
Year Range
0.29 - 4.313
Trading Volume
187,133,434
1 Day Change
129.25%
5 Day Change
163.18%
1 Month Change
99.95%
3 Month Change
-43.38%
6 Month Change
-60.88%
Ytd Change
-77.47%
1 Year Change
-72.94%
3 Year Change
-91.15%
5 Year Change
-91.17%
10 Year Change
-91.17%
Max Change
-91.17%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.